Oxford is world-famous for research excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research sparks imaginative and inventive insights and solutions.

Photo | Technician working in the lab, Nanoro

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.

Photo | close up of a spray bottle drops on black background

University of Oxford to study nasal administration of COVID-19 vaccine

The Phase I trial, which will enrol 30 healthy volunteers aged 18–40, will investigate the level of immune system responses generated by the vaccine using this delivery technique, as well as monitoring safety and for any adverse reactions.

‘Citizen scientists’ help researchers gather new insights into polar bear behaviour

‘Citizen scientists’ help researchers gather new insights into polar bear behaviour

The Arctic Bears Project is being led by Professor Douglas Clark, of the University of Saskatchewan, in collaboration with penguinologist Dr Tom Hart of Oxford’s Department of Zoology.

RECOVERY trial participant takes antibiotic

PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19

Azithromycin and doxycycline are two commonly used antibiotics investigated as separate treatments in the trial. Both drugs are being used by some doctors in the hope of treating COVID-19 in the early stages of the illness.

Domesday Book Cover

New insights from original Domesday survey revealed

A new interpretation of the survey behind Domesday Book – the record of conquered England compiled on the orders of William the Conqueror in 1086 – has emerged from a major new study of the survey’s earliest surviving manuscript.

Photo | Researcher working on immunology in the lab

Oxford vaccine stimulates broad antibody and T cell functions

These findings are reported in two papers, both released in the peer-reviewed journal Nature Medicine.

infographic highlighting ethnic inequalities in maternal mortality

Driving policy change to prevent maternal deaths

Impact case study

The MBRRACE programme is influencing policy and services to support pregnant women and prevent maternal deaths.
statue showing refugees

Boosting life chances for resettled refugees

Impact case study

Software developed by an international team including Dr Alex Teytelboym from Oxford University is helping to resettle refugees in communities where they are more likely to flourish.
diagram of how Simon works

SIMON Says…

Impact case study

Researchers at Oxford Vaccine Group have developed machine learning software to predict the efficacy of flu vaccines, offering huge potential for other vaccine research.
LitHits logo

Right book… right time… right place

Impact case study

Kirsten Shepherd-Barr and colleagues have developed the award-winning LitHits app, which allows users to access great literature in unexpected ways.
photographic proof sheet

Blow-up in Bissau

Impact case study

A photographic exhibition organised by Dr Ramon Sarró and colleagues has helped re-establish the National Ethnographic Museum in Guinea-Bissau.
Anatolian coins

New project explores the origins of money

The CHANGE Project is led by Professor Andrew Meadows, a Fellow and Tutor in Ancient History at New College and former Curator of Greek Coins at the British Museum.

Photo | Crowd of people walking

New research confirms obesity is a cause of kidney disease

Funded by Kidney Research UK and the Medical Research Council, this new study has found that fat all over the body increases risk, not just fat around the middle (tummy fat), and suggests controlling weight could be a new way to manage kidney disease risk.

Photo | Vials in preparation for a vaccine

Trials of Oxford coronavirus vaccine begin in Kenya

Our vaccine work is progressing quickly.

Pages

Was this page useful?*